美国 · 平台与数据 · Finviz
Kura Oncology to Report Third Quarter Financial Results on November 10
Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced it will report its third quarter 2026…
在 Finviz 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (finviz.com)




